DK362989A - Analoge af fibroblastvaekstfaktor - Google Patents

Analoge af fibroblastvaekstfaktor Download PDF

Info

Publication number
DK362989A
DK362989A DK362989A DK362989A DK362989A DK 362989 A DK362989 A DK 362989A DK 362989 A DK362989 A DK 362989A DK 362989 A DK362989 A DK 362989A DK 362989 A DK362989 A DK 362989A
Authority
DK
Denmark
Prior art keywords
analogue
growth factor
fibroblast growth
fibroblast
factor
Prior art date
Application number
DK362989A
Other languages
Danish (da)
English (en)
Other versions
DK362989D0 (da
Inventor
Tsutomu Arakawa
Gary M Fox
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of DK362989D0 publication Critical patent/DK362989D0/da
Publication of DK362989A publication Critical patent/DK362989A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK362989A 1987-11-24 1989-07-21 Analoge af fibroblastvaekstfaktor DK362989A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12489687A 1987-11-24 1987-11-24
US27152188A 1988-11-17 1988-11-17

Publications (2)

Publication Number Publication Date
DK362989D0 DK362989D0 (da) 1989-07-21
DK362989A true DK362989A (da) 1989-09-25

Family

ID=26823063

Family Applications (1)

Application Number Title Priority Date Filing Date
DK362989A DK362989A (da) 1987-11-24 1989-07-21 Analoge af fibroblastvaekstfaktor

Country Status (9)

Country Link
EP (1) EP0320148A1 (ja)
JP (1) JPH02504468A (ja)
KR (1) KR890701607A (ja)
AU (1) AU638402B2 (ja)
DK (1) DK362989A (ja)
FI (1) FI893530A0 (ja)
NZ (1) NZ227057A (ja)
PT (1) PT89081B (ja)
WO (1) WO1989004832A1 (ja)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2526965B2 (ja) * 1987-02-24 1996-08-21 武田薬品工業株式会社 ムテイン，ｄｎａおよびその用途
US5175147A (en) * 1988-08-19 1992-12-29 Takeda Chemical Industries, Ltd Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract
US7049102B1 (en) 1989-09-22 2006-05-23 Board Of Trustees Of Leland Stanford University Multi-gene expression profile
CA2070989A1 (en) * 1989-12-19 1991-06-20 Kazuaki Kitano Production of human basic fgf mutein
US5612211A (en) * 1990-06-08 1997-03-18 New York University Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors
US5206354A (en) * 1990-11-23 1993-04-27 American Cyanamid Company Dna sequence encoding active fragment of fibroblast growth factor, hbf-2
ES2087207T3 (es) * 1990-11-23 1996-07-16 American Cyanamid Co Factor del crecimiento de fibroblasto quimerico.
JP3135138B2 (ja) * 1990-12-19 2001-02-13 科研製薬株式会社 骨疾患治療剤
US6833354B1 (en) 1990-12-19 2004-12-21 Kaken Pharmaceutical Co., Ltd. Agent for the treatment of bone diseases
GB9100381D0 (en) * 1991-01-09 1991-02-20 Erba Carlo Spa Human bfgf derivatives,their analogs and process for their production
JP3303211B2 (ja) * 1991-04-26 2002-07-15 武田薬品工業株式会社 ｂＦＧＦムテインおよびその製造法
HUT67217A (en) * 1992-02-14 1995-03-28 Kaken Pharma Co Ltd Remedy for airway diseases
US5461029A (en) * 1992-04-24 1995-10-24 American Cyanamid Company Method of treating herpes viral infections using HBNF and MK proteins
CA2168647A1 (en) * 1993-08-02 1995-02-09 Barbara A. Sosnowski Monogenous preparations of cytotoxic conjugates
TW275068B (ja) * 1993-09-24 1996-05-01 American Cyanamid Co
US6399386B1 (en) 1994-07-22 2002-06-04 President And Fellows Of Harvard College Method of isolating receptor and ligand DNA
US5766923A (en) * 1994-07-22 1998-06-16 President & Fellows Of Harvard College Isolated nucleic acid encoding ligands for FGFR
KR100374310B1 (ko) * 1995-02-14 2003-05-22 주식회사 엘지생명과학 변형된인간염기성섬유아세포성장인자및이의생산방법
AU3170499A (en) * 1998-04-28 1999-11-16 Eisai Co. Ltd. Fibroblast growth factor mutein compositions and methods of use therefor
US6451303B1 (en) 1998-10-13 2002-09-17 Chiron Corporation Method of treating coronary artery disease by administering a recombinant FGF
US6440934B1 (en) 1998-10-13 2002-08-27 Chiron Corporation Angiogenically effective unit dose of FGF-2 and method of use
US20030166550A1 (en) 1999-08-27 2003-09-04 Chiron Corporation Angiogenically effective unit dose of FGF-2 and method of use
US8618052B2 (en) 1998-10-13 2013-12-31 Novartis Vaccines And Diagnostics, Inc. Method of treating coronary artery disease by administering FGF-5
US20020072489A1 (en) 1998-10-13 2002-06-13 Whitehouse Martha J. Angiogenically effective unit dose of FGF-2 and method of use
CA2381780C (en) 1999-08-13 2015-03-10 Chiron Corporation Dose of an angiogenic factor and method of administering to improve myocardial blood flow
EP1541674B9 (en) 2002-06-18 2011-09-14 Eisai R&D Management Co., Ltd. Primary cultured adipocytes for gene therapy
WO2005087257A1 (ja) * 2004-03-16 2005-09-22 Kaken Pharmaceutical Co., Ltd. 架橋ゼラチンゲルを担体とする軟骨組織修復治療剤
CN108324928B (zh) * 2018-03-05 2020-09-08 哈尔滨医科大学 重组人成纤维细胞生长因子-5在促骨折愈合中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4296100A (en) * 1980-06-30 1981-10-20 Franco Wayne P Method of treating the heart for myocardial infarction
US4956455A (en) * 1984-03-05 1990-09-11 The Salk Institute For Biological Studies Bovine fibroblast growth factor
AU590006B2 (en) * 1985-09-12 1989-10-26 Scios Nova Inc. Recombinant fibroblast growth factors

Also Published As

Publication number Publication date
AU2818189A (en) 1989-06-14
AU638402B2 (en) 1993-07-01
PT89081A (pt) 1989-11-30
WO1989004832A1 (en) 1989-06-01
EP0320148A1 (en) 1989-06-14
NZ227057A (en) 1990-12-21
FI893530A (fi) 1989-07-21
DK362989D0 (da) 1989-07-21
FI893530A0 (fi) 1989-07-21
KR890701607A (ko) 1989-12-21
PT89081B (pt) 1993-09-30
JPH02504468A (ja) 1990-12-20

Similar Documents

Publication Publication Date Title
DK362989A (da) Analoge af fibroblastvaekstfaktor
DK2490D0 (da) Rekombinante fibroblastvaekstfaktorer
FR2605214B1 (fr) Prothese perihepatique
DK0410711T3 (da) Protese
DK510388D0 (da) Produktion af en fibroblast-vaekstfaktor
NO173485C (no) Resorberbar protese
FR2617040B1 (fr) Prothese cotyloidienne
DE69125659D1 (de) Modifikation der Kristallzüchtung
DK539587D0 (da) Faktor viii-c analoge
FR2634382B1 (fr) Pancreas artificiel
DK62589D0 (da) Kloning og ekspression af human vaekstfaktor
DE3890771T1 (de) Intraokularlinse zur korrektion von ametropie
DK116390A (da) Accellerering af knogledannelse med gm-csf
FR2611486B1 (fr) Prothese uretrale
DE69314443T2 (de) Analoge multifunktionsuhr mit abnehmbarem teilstück
FR2610822B1 (fr) Prothese de hanche
KR880019015U (ko) 분리식 하지구
KR900701835A (ko) Crf 유사체
DK420185D0 (da) Anvendelse af somatostatinanaloge
DK153145C (da) 1alfa-hydroxyvitamin d2 analoge
DE69121210D1 (de) Therapeutische verwendung des fibroblastenwachstumsfaktors
DK398888A (da) Moentboksdepot med vippebund
NO892992L (no) Analoger av fibroblast-vekstfaktor.
DK343087A (da) Analoge af atriale natriuretiske peptider
NO884109L (no) Fremstilling av fibroblastvekstfaktor.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment